Allergan's sales rose by 9.0 percent to $1,365.7 million in the first quarter, or by 10.4 percent in constant currencies. In particular, specialty pharmaceuticals went up by 10.8 percent in dollars and by 12.2 percent in local currencies.
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.